Lymphogranuloma	0	14
venereum	16	23
presenting	25	34
as	36	37
perianal	39	46
ulceration	48	57
:	58	58
an	60	61
emerging	63	70
clinical	72	79
presentation	81	92
?	93	93

An	95	96
outbreak	98	105
of	107	108
lymphogranuloma	110	124
venereum	126	133
(	135	135
LGV	136	138
)	139	139
infection	141	149
has	151	153
been	155	158
recognised	160	169
in	171	172
the	174	176
UK	178	179
since	181	185
2004	187	190
,	191	191
predominantly	193	205
affecting	207	215
HIV	217	219
-	220	220
positive	221	228
men	230	232
who	234	236
have	238	241
sex	243	245
with	247	250
men	252	254
(	256	256
MSM	257	259
)	260	260
.	261	261

Patients	263	270
typically	272	280
present	282	288
with	290	293
proctitis	295	303
symptoms	305	312
.	313	313

The	315	317
prevalence	319	328
of	330	331
rectal	333	338
LGV	340	342
in	344	345
MSM	347	349
attending	351	359
sexually	361	368
transmitted	370	380
infection	382	390
clinics	392	398
in	400	401
London	403	408
is	410	411
estimated	413	421
at	423	424
1	426	426
%	427	427
.	428	428

Health	430	435
Protection	437	446
Agency	448	453
surveillance	455	466
has	468	470
shown	472	476
a	478	478
decrease	480	487
in	489	490
anorectal	492	500
manifestations	502	515
despite	517	523
little	525	530
demographic	532	542
change	544	549
.	550	550

Two	552	554
cases	556	560
of	562	563
HIV	565	567
-	568	568
infected	569	576
patients	578	585
presenting	587	596
with	598	601
isolated	603	610
perianal	612	619
ulcer	621	625
disease	627	633
are	635	637
reported	639	646
here	648	651
.	652	652

Both	654	657
cases	659	663
were	665	668
confirmed	670	678
to	680	681
have	683	686
rectal	688	693
Chlamydia	695	703
trachomatis	705	715
-	716	716
specific	717	724
DNA	726	728
of	730	731
an	733	734
LGV	736	738
associated	740	749
serovar	751	757
.	758	758

As	760	761
presentations	763	775
of	777	778
LGV	780	782
diversify	784	792
,	793	793
further	795	801
education	803	811
and	813	815
surveillance	817	828
are	830	832
needed	834	839
in	841	842
order	844	848
to	850	851
reduce	853	858
transmission	860	871
and	873	875
prevent	877	883
long	885	888
-	889	889
term	890	893
complications	895	907
.	908	908

A	910	910
strong	912	917
argument	919	926
already	928	934
exists	936	941
for	943	945
the	947	949
incorporation	951	963
of	965	966
chlamydia	968	976
nucleic	978	984
acid	986	989
amplification	991	1003
tests	1005	1009
in	1011	1012
the	1014	1016
management	1018	1027
of	1029	1030
MSM	1032	1034
with	1036	1039
proctitis	1041	1049
;	1050	1050
this	1052	1055
paper	1057	1061
provides	1063	1070
evidence	1072	1079
that	1081	1084
this	1086	1089
should	1091	1096
be	1098	1099
extended	1101	1108
to	1110	1111
MSM	1113	1115
with	1117	1120
perianal	1122	1129
ulcer	1131	1135
disease	1137	1143
.	1144	1144
